Temazepam Dose Escalation for Inadequate Sleep Response

Evidence-Based Dosing Algorithm

The American Academy of Sleep Medicine recommends increasing temazepam to 30 mg at bedtime if 15 mg provides inadequate relief of insomnia, which demonstrates clinically meaningful improvements in sleep latency and total sleep time compared to placebo 1, 2
Increasing to 30 mg at bedtime represents the maximum recommended dose and shows superior efficacy on sleep staging parameters compared to 15 mg 1, 2

A 15 mg dose of temazepam increases total sleep time by 64.4 minutes (moderate-quality evidence) and improves sleep efficiency by 13.3% on polysomnography 1, 2
A 30 mg dose of temazepam reduces sleep latency by 40-45 minutes compared to placebo and increases total sleep time by 53-78 minutes 1, 2
A 30 mg dose of temazepam decreases the number of awakenings by 1.0-1.24 per night and demonstrates statistically significant improvement in sleep quality ratings 1, 2

At 15 mg, temazepam shows no notable increase in adverse effects versus placebo, with no significant daytime impairment 1, 2
At 30 mg, temazepam is associated with an increased incidence of drowsiness, lethargy, and vertigo compared to lower doses 1, 2
Daytime impairment on cognitive tests is more common at 30 mg 1, 2

Benzodiazepines, including temazepam, are associated with dementia risk in observational studies, with the greatest effect for higher-dose hypnotics and agents with half-lives exceeding 24 hours 3, 4

If a patient experiences drowsiness, fatigue, or cognitive impairment at 15 mg, do not increase to 30 mg 1, 2
Consider alternative agents before escalating to 30 mg if concerns about benzodiazepine risks exist 5
The American Academy of Sleep Medicine rates all benzodiazepine recommendations as "WEAK" strength, indicating many patients might reasonably choose alternative treatments 5